G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,667,000 | +33.7% | 69,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,247,000 | +52.4% | 69,300 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $818,000 | -51.1% | 70,800 | +2.6% | 0.00% | -50.0% |
| Q2 2020 | $1,674,000 | +101.9% | 69,000 | -8.3% | 0.00% | +100.0% |
| Q1 2020 | $829,000 | -59.7% | 75,262 | -3.3% | 0.00% | -50.0% |
| Q4 2019 | $2,058,000 | +34.5% | 77,862 | +15.9% | 0.00% | 0.0% |
| Q3 2019 | $1,530,000 | +58.4% | 67,162 | +113.2% | 0.00% | +100.0% |
| Q2 2019 | $966,000 | +75.6% | 31,500 | -4.9% | 0.00% | 0.0% |
| Q1 2019 | $550,000 | -40.1% | 33,126 | -30.9% | 0.00% | 0.0% |
| Q4 2018 | $918,000 | -65.5% | 47,951 | -5.9% | 0.00% | -66.7% |
| Q3 2018 | $2,664,000 | +62.1% | 50,951 | +34.8% | 0.00% | +50.0% |
| Q2 2018 | $1,643,000 | – | 37,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |